Notably, the surface levels of CD3 were decreased on both CD4+ and CD8+ tumor-infiltrating T cells in αCD40-treated groups (Fig. 6i, j), which is in line with a CD11b-mediated internalization of the TCR complex as previously reported37. The gene discussed is CD8A; the disease is neoplasm.